Ron Cahill was quoted in a Fierce Pharma article, "Supreme Court unlikely to take up Coreg skinny label feud after Teva's $235M loss to GSK, lawyer says."
Media Mentions
Supreme Court unlikely to take up Coreg skinny label feud after Teva's $235M loss to GSK, lawyer says
November 3, 2022
Boston
RELATED PEOPLE
×
Subscribe
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you're interested in learning more about.
View Subscription Center
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2023-10-27-22-14-47-460-653c3657aa16c1a78944a4ac.jpg)
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2024-06-15-03-35-36-968-666d0c08c56a9fccba9e64ea.jpg)
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2024-06-17-15-30-39-269-6670569f086c06c316400926.jpg)
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2024-04-10-12-04-21-213-66168045b21e7b3ad70f8900.jpg)